The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

“Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the past. That is why this ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect ... Harris Administration and HHS,” HHS Secretary Xavier Becerra said in a statement Friday.

“This latest intended investment illustrates the Biden-Harris Administration’s robust response to emerging disease threats such as avian influenza,” said Health Secretary Xavier Becerr ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

The US government has awarded Moderna US$590 million (S$807 million) to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in ...

"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra. Companies ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu ... HHS Secretary Xavier Becerra said in a statement ...

Jan 17 (Reuters) - The U.S. government has awarded Moderna (MRNA.O), opens new tab $590 million to advance the development of its bird flu vaccine ... HHS Secretary Xavier Becerra said in a ...